Global Eubiotics Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

Description

List of Tables

Global Eubiotics Market size is anticipated to grow from USD 9.33 Billion in 2024 to USD 18.29 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 7.76% during the forecast period of 2026 to 2033.

The eubiotics market is poised for remarkable growth as the global focus on health and wellness intensifies. Eubiotics, which encompass prebiotics, probiotics, and postbiotics, are gaining traction for their ability to promote gut health and overall well-being. As consumers become increasingly aware of the link between gut microbiota and various health outcomes, the demand for eubiotic products is surging. This trend is particularly evident in the food and beverage sector, where manufacturers are incorporating eubiotic ingredients into functional foods and dietary supplements. As the market continues to evolve, innovations in formulation and delivery methods are expected to enhance the effectiveness and appeal of eubiotic products, driving further growth.

Moreover, the rise of the clean label movement is significantly influencing the eubiotics market. Consumers are increasingly seeking transparency in ingredient sourcing and formulation, leading to a preference for natural and minimally processed eubiotic options. This shift is prompting manufacturers to invest in research and development to create high-quality, effective products that align with consumer values. Additionally, the growing interest in personalized nutrition is driving the demand for tailored eubiotic solutions that cater to individual health needs. As the market adapts to these trends, it is likely to witness sustained growth, appealing to a diverse range of consumers seeking to enhance their health through gut microbiome support.

Furthermore, the eubiotics market is benefiting from advancements in scientific research that highlight the health benefits of these products. As studies continue to uncover the complex interactions between gut health and various physiological processes, the demand for eubiotic solutions is expected to rise. This growing body of evidence is not only bolstering consumer confidence but also encouraging healthcare professionals to recommend eubiotic products as part of holistic health strategies. As awareness of the importance of gut health continues to spread, the eubiotics market is set to thrive, positioning itself as a key player in the health and wellness industry.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Type

Probiotics
Prebiotics
Organic acids
Essential oils

By Livestock

Poultry
Swine
Ruminants
Aquatic animals
Others (horses, sheep, and birds)

By Function

Nutrition and gut health
Yield
Immunity
Production

By Form

Dry
Liquid
COMPANIES PROFILED
Cargill
BASF
E. I. du Pont de Nemours and Company
Koninklijke DSM
Chr. Hansen
Novozymes
Calpis
Lesaffre
Kemin Industries
Lallemand
ADDCON
Behn Meyer
Novus International
Advanced BioNutrition Corporation.
The above list can be customized.

Product Code: VMR112110645

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. EUBIOTICS INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Livestock
- 3.7.3 Market Attractiveness Analysis By Function
- 3.7.4 Market Attractiveness Analysis By Form
- 3.7.5 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL EUBIOTICS MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. Probiotics Historic and Forecast Sales By Regions
5.4. Prebiotics Historic and Forecast Sales By Regions
5.5. Organic acids Historic and Forecast Sales By Regions
5.6. Essential oils Historic and Forecast Sales By Regions

6. GLOBAL EUBIOTICS MARKET ANALYSIS BY LIVESTOCK

6.1. Overview By Livestock
6.2. Historical and Forecast Data Analysis By Livestock
6.3. Poultry Historic and Forecast Sales By Regions
6.4. Swine Historic and Forecast Sales By Regions
6.5. Ruminants Historic and Forecast Sales By Regions
6.6. Aquatic animals Historic and Forecast Sales By Regions
6.7. Others (horses, sheep, and birds) Historic and Forecast Sales By Regions

7. GLOBAL EUBIOTICS MARKET ANALYSIS BY FUNCTION

7.1. Overview By Function
7.2. Historical and Forecast Data Analysis By Function
7.3. Nutrition and gut health Historic and Forecast Sales By Regions
7.4. Yield Historic and Forecast Sales By Regions
7.5. Immunity Historic and Forecast Sales By Regions
7.6. Production Historic and Forecast Sales By Regions

8. GLOBAL EUBIOTICS MARKET ANALYSIS BY FORM

8.1. Overview By Form
8.2. Historical and Forecast Data Analysis By Form
8.3. Dry Historic and Forecast Sales By Regions
8.4. Liquid Historic and Forecast Sales By Regions

9. GLOBAL EUBIOTICS MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE EUBIOTICS COMPANIES

10.1. Eubiotics Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF EUBIOTICS INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Cargill
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. BASF
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. E. I. Du Pont De Nemours And Company
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Koninklijke DSM
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Chr. Hansen
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Novozymes
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Calpis
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Lesaffre
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Kemin Industries
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Lallemand
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments
11.13. ADDCON
- 11.13.1 Company Overview
- 11.13.2 Company Revenue
- 11.13.3 Products
- 11.13.4 Recent Developments
11.14. Behn Meyer
- 11.14.1 Company Overview
- 11.14.2 Company Revenue
- 11.14.3 Products
- 11.14.4 Recent Developments
11.15. Novus International
- 11.15.1 Company Overview
- 11.15.2 Company Revenue
- 11.15.3 Products
- 11.15.4 Recent Developments
11.16. Advanced BioNutrition Corporation
- 11.16.1 Company Overview
- 11.16.2 Company Revenue
- 11.16.3 Products
- 11.16.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies